News

Orchestra BioMed Press Release NEW HOPE, Pa., April 30, 2026 -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) (“Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through strategic...

iRhythm Holdings Press Release SAN FRANCISCO, April 27, 2026 -- iRhythm Holdings, Inc. (NASDAQ:IRTC) today announced results from two real-world retrospective analyses in post-ablation and pregnancy patient populations presented...

 Heart Rhythm Society Press Release CHICAGO, IL, APRIL 26, 2026 – New results from the pivotal multicenter trial FULCRUM-VT show that ultra-low temperature ablation (ULTA) may offer a promising new treatment option for patients...

HRS Press Release CHICAGO, IL, APRIL 26, 2026 – New results from the multicenter Catheter Ablation versus Anti-arrhythmic Drugs for Ventricular Tachycardia (CAAD-VT) trial show that catheter ablation may reduce ventricular tachycardia...

HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT)

Abbott Press Release ABBOTT PARK, Ill., April 25, 2026 -- Abbott (NYSE: ABT) today announced new late-breaking data from four trials that demonstrate strong clinical outcomes within its pulsed field ablation (PFA) and conduction...

HRS Press Release CHICAGO, IL, APRIL 24, 2026 – A new analysis from the NOAH – AFNET 6 trial shows that artificial intelligence (AI) can help unlock data from pacemakers to better understand stroke risk in patients with...

Johnson & Johnson Press Release NEW BRUNSWICK, N.J. – April 24, 2026 – Johnson & Johnson (NYSE: JNJ) has entered into a definitive agreement to acquire Atraverse Medical, Inc., a privately-held medical device company...

HRS Press Release CHICAGO, IL, APRIL 24, 2026 – The Heart Rhythm Society announced the first analysis of its Centers of Excellence Optimal Management Pathways for Atrial Fibrillation Specialty Services Early...

Haemonetics Press Release BOSTON, April 24, 2026 -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced...